Education
About Us
Working with TipRanks
Follow Us
Medifast Inc (MED)
NYSE:MED
MED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$11.57 - $21.98
Previous CloseN/A
Volume160.90K
Average Volume (3M)160.36K
Market Cap
$157.72M
Enterprise Value$5.79M
Total Cash (Recent Filing)$162.67M
Total Debt (Recent Filing)$13.07M
Price to Earnings (P/E)43.5
Beta0.39
Next Earnings
Feb 24, 2026EPS EstimateN/A
Last Dividend Ex-Date
Sep 18, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)0.40
Shares Outstanding10,991,064
10 Day Avg. Volume148,226
30 Day Avg. Volume160,364
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.04
Enterprise Value/Revenue0.01
Enterprise Value/Gross Profit0.02
Enterprise Value/Ebitda0.41
Forecast
1Y Price Target
$14.00Price Target Upside-2.44% Downside
Rating ConsensusHold
Number of Analyst Covering0
Medifast News
MED FAQ
What was Medifast Inc’s price range in the past 12 months?
Medifast Inc lowest stock price was $11.57 and its highest was $21.98 in the past 12 months.
What is Medifast Inc’s market cap?
Medifast Inc’s market cap is $157.72M.
When is Medifast Inc’s upcoming earnings report date?
Medifast Inc’s upcoming earnings report date is Feb 24, 2026 which is in 154 days.
How were Medifast Inc’s earnings last quarter?
Medifast Inc released its earnings results on Aug 04, 2025. The company reported $0.401 earnings per share for the quarter, beating the consensus estimate of -$0.19 by $0.591.
Is Medifast Inc overvalued?
According to Wall Street analysts Medifast Inc’s price is currently Overvalued.
Does Medifast Inc pay dividends?
Medifast Inc pays a Quarterly dividend of $1.65 which represents an annual dividend yield of N/A. See more information on Medifast Inc dividends here
What is Medifast Inc’s EPS estimate?
Medifast Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medifast Inc have?
Medifast Inc has 10,991,064 shares outstanding.
What happened to Medifast Inc’s price movement after its last earnings report?
Medifast Inc reported an EPS of $0.401 in its last earnings report, beating expectations of -$0.19. Following the earnings report the stock price went down -3.257%.
Which hedge fund is a major shareholder of Medifast Inc?
Currently, no hedge funds are holding shares in MED
Medifast Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.00 (-2.44% Downside)
$14.00 (-2.44% Downside)
Blogger Sentiment
Bullish
MED Sentiment 66%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Decreased
By 294.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.43%
12-Months-Change
Fundamentals
Return on Equity
1.73%
Trailing 12-Months
Asset Growth
-8.24%
Trailing 12-Months
Company Description
Medifast Inc
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
MED Company Deck
MED Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call presented a mixed picture: while Medifast reported some positive developments such as exceeding guidance, improving coach productivity, and a strong financial position, these were overshadowed by significant declines in revenue and active coaches, as well as challenges in new coach acquisition. The company's cautious third quarter guidance further indicates ongoing struggles.View all MED earnings summariesTechnical Analysis
Ownership Overview
4.71% Insiders
14.54% Mutual Funds
8.82% Other Institutional Investors
53.36% Public Companies and
Individual Investors